George A. Joulwan

Insider Reports History

Entity
Individual
Signature
/s/ S. Scott Lieberman, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by George A. Joulwan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Emergent BioSolutions Inc. Director Common Stock 40.2K $73.2K $1.82 May 26, 2022 Direct

Insider Reports Filed by George A. Joulwan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EBS Emergent BioSolutions Inc. May 26, 2022 1 $0 4 May 31, 2022 Director
EBS Emergent BioSolutions Inc. May 20, 2021 1 $0 4 May 24, 2021 Director